A Phase 3, Randomized, Multicenter, Single-blind, Controlled Study Evaluating Arteriovenous Fistula Outcomes With and Without a Perivascular Sirolimus-Eluting Collagen Implant
Phase of Trial: Phase III
Latest Information Update: 17 Nov 2017
At a glance
- Drugs Sirolimus (Primary)
- Indications Arteriovenous fistula
- Focus Therapeutic Use
- Acronyms ACCESS
- Sponsors Vascular Therapies
- 17 Nov 2017 New trial record
- 09 Nov 2017 According to a Vascular Therapies media release, topline results are expected in 2019.
- 09 Nov 2017 According to a Vascular Therapies media release, this trial is conducted under a Special Protocol Assessment (SPA).